Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Local Anesthetics: Differential Sensitivity of Nerve Fibers01:24

Local Anesthetics: Differential Sensitivity of Nerve Fibers

988
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
988
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

51
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
51
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

83
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
83

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep quality is influenced by multiple factors and cannot be reduced to the volume of pineal gland calcification.

Arquivos de neuro-psiquiatria·2026
Same author

Guillain-Barre syndrome should not be considered to be caused by an acute Zika infections unless PCR test for viral RNA is positive.

Tropical doctor·2026
Same author

Before Attributing Cervical Myelopathy to Diabetes, All Other Causes Must Be Convincingly Ruled Out.

Neurology India·2026
Same author

Anatomic Insights and Surgical Applications of the Trochlear Nerve: An Underappreciated Landmark for Safe and Effective Posterior Fossa Surgery.

Operative neurosurgery (Hagerstown, Md.)·2026
Same author

Capturing Stereoscopic Three-Dimensional Images with a Cellphone Camera for Neuroanatomical Documentation: A Step-by-Step Guide.

World neurosurgery·2026
Same author

Planetary health: Real challenges for elderly population.

Clinics (Sao Paulo, Brazil)·2026
Same journal

Editorial.

Acta neurologica Scandinavica·2022
Same journal

Advances in sudden unexpected death in epilepsy.

Acta neurologica Scandinavica·2022
Same journal

Non-convulsive seizures and non-convulsive status epilepticus in neuro-intensive care unit.

Acta neurologica Scandinavica·2022
Same journal

Positron emission tomography in autoimmune encephalitis: Clinical implications and future directions.

Acta neurologica Scandinavica·2022
Same journal

Seizure detection based on wearable devices: A review of device, mechanism, and algorithm.

Acta neurologica Scandinavica·2022
Same journal

Walking confidence and perceived locomotion ability explain participation after stroke: A cross-sectional experimental study.

Acta neurologica Scandinavica·2022
See all related articles

Related Experiment Video

Updated: Oct 4, 2025

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.7K

Small fiber neuropathy.

Josef Finsterer1,2, Fulvio A Scorza2

  • 1Neurology & Neurophysiology Center, Vienna, Austria.

Acta Neurologica Scandinavica
|February 7, 2022
PubMed
Summary
This summary is machine-generated.

Small fiber neuropathy (SFN) treatment requires a multimodal approach, addressing underlying causes, symptoms like pain, and improving function. Individualized care based on diagnosis and etiology is crucial for effective management of this peripheral nervous system disease.

Keywords:
autonomic dysfunctionoutcomepainsmall fiber neuropathytreatment

More Related Videos

Corneal Confocal Microscopy: A Novel Non-invasive Technique to Quantify Small Fibre Pathology in Peripheral Neuropathies
11:29

Corneal Confocal Microscopy: A Novel Non-invasive Technique to Quantify Small Fibre Pathology in Peripheral Neuropathies

Published on: January 3, 2011

26.8K
Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies
11:22

Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies

Published on: April 29, 2013

13.3K

Related Experiment Videos

Last Updated: Oct 4, 2025

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.7K
Corneal Confocal Microscopy: A Novel Non-invasive Technique to Quantify Small Fibre Pathology in Peripheral Neuropathies
11:29

Corneal Confocal Microscopy: A Novel Non-invasive Technique to Quantify Small Fibre Pathology in Peripheral Neuropathies

Published on: January 3, 2011

26.8K
Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies
11:22

Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies

Published on: April 29, 2013

13.3K

Area of Science:

  • Neurology
  • Peripheral Nervous System Disorders
  • Pain Management

Background:

  • Small fiber neuropathy (SFN) affects A-delta or C-fibers, causing pain, sensory changes, or autonomic dysfunction.
  • Diagnosis often relies on clinical features and reduced intra-epidermal nerve fiber density, despite lacking uniform criteria.
  • Treatment consensus for SFN remains limited, necessitating a review of current options.

Purpose of the Study:

  • To summarize and discuss available treatment options for small fiber neuropathy (SFN).
  • To highlight the importance of diagnosis and etiology in guiding SFN treatment strategies.

Main Methods:

  • This narrative review synthesizes information on SFN treatment modalities.
  • Classifies treatments into symptomatic, pathophysiologic, and causal approaches.

Main Results:

  • Symptomatic treatments include pain relievers, antidepressants, anti-seizure drugs, and topical agents for pain.
  • Pathophysiologic therapies target specific conditions like Fabry disease, hATTR, or immune-mediated SFN.
  • Causal treatments address the underlying disorders responsible for secondary SFN.

Conclusions:

  • Effective SFN management necessitates a multimodal strategy combining causative, pathophysiologic, and symptomatic measures.
  • Individualized treatment plans are essential, focusing on the patient's specific presentation, diagnosis, and etiology.
  • The primary goals are controlling the underlying cause, alleviating pain, and optimizing patient functionality.